FPA: Set, Administration, Intravascular

Product code FPA, “Set, Administration, Intravascular” in FDA's classification database, is a Class II device type under 21 CFR 880.5440 (intravascular administration set), reviewed by FDA's General Hospital panel. FDA's 510(k) database lists 1,175 clearances under FPA, 196 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
FPA
Regulation
21 CFR 880.5440
Class
II
Panel
General Hospital
Clearances
1,175
Most recent
Sep 11, 2026
Median review, last 2 years
232 days
Third-party review
Eligible
Implant
No

What it covers

An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container.

The identification in 21 CFR 880.5440, intravascular administration set. FDA gives FPA no definition of its own, so the regulation’s describes it.

Recent clearances

510(k)DeviceApplicantDecisionType
K254123Ecomed Disposable Administration SetsEcomed Solutions, LLCSep 11, 2026Abbreviated
K261530iiSure Infusion SetDeka Research and DevelopmentJun 3, 2026Special
K252543AMSafe Administration Set (BA-70075, BA-70071-D, BA-70070, BA-70071-P, BA-70072, BA-70072-F, BA-70071-DF, BA-70071-DF-120, FE01, FE04)Amsino International, Inc.May 4, 2026Traditional
K251375PuraCath Firefly Needleless Connector IT (9005)Puracath Medical, Inc.Feb 12, 2026Traditional
K251257nSet+ Stabilization Set [6426733]; nSet+ Stabilization Set with nSyte Needle Free Connector (NFC) [6426731]; nSyte Needle Free Connector (NFC) [6426727]Np MedicalDec 4, 2025Traditional
K250325BD Alaris Pump Infusion SetCarefusion (Bd)Oct 30, 2025Traditional
K251814EZ™ IV Administration SetEpic Medical Pte. , Ltd.Aug 29, 2025Traditional
K251854SteadiSet infusion setTandem Diabetes CareAug 6, 2025Abbreviated
K243841Sparta Infusion Set for InsulinDeka Research and DevelopmentAug 1, 2025Traditional
K243392Infusomat® Space Volumetric Infusion Pump Administration SetsB.Braun Medical, Inc.Jul 24, 2025Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 1,175 with a free account)

Clearances by year

196 FPA 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)4266
202511225
20247244
202314340
202214213
202113186
202010327
20197161
20184177
201717240
201612195
201515123
20142289
20131390
20122196
20111287

Who submits

99 applicants cleared a FPA device since 2011. 69% of the clearances went to applicants in United States, then China (11%), Denmark (3%) and Türkiye (3%). By type: Traditional 80%, Special 16% and Abbreviated 5%. 14 went through a third-party review organization.

ApplicantClearances since 2011
Baxter Healthcare Corporation16
B.Braun Medical, Inc.13
Hospira, Inc.11
Quest Medical, Inc.7
Care Fusion6
Unomedical A/S6
Baxter Healthcare Corp5
Nexus Medical, LLC5

How FDA classifies it

Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.

From 21 CFR 880.5440. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 880.5440 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent FPA clearances declared.

Ask about FPA

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about FPA

What is FDA product code FPA?

Product code FPA, “Set, Administration, Intravascular” in FDA's classification database, is a Class II device type under 21 CFR 880.5440 (intravascular administration set), reviewed by FDA's General Hospital panel. FDA's 510(k) database lists 1,175 clearances under FPA, 196 of them since 2011.

How many 510(k) clearances are there under FPA?

FDA’s 510(k) database listed 1,175 clearances under FPA as of Oct 29, 2026, 196 of them decided since 2011; the most recent decision was Sep 11, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a FPA 510(k)?

For the 16 FPA clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 232 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most FPA clearances?

Since 2011: Baxter Healthcare Corporation (16), B.Braun Medical, Inc. (13), Hospira, Inc. (11), Quest Medical, Inc. (7) and Care Fusion (6). 99 applicants have cleared a FPA device in that time.

Sources

  1. FDA product classification: FPA · Product Classification database
  2. 21 CFR 880.5440: Intravascular administration set · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for FPA · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow FPAGet an email when FDA clears, recalls or publishes guidance for FPA devices.

Know what FDA already cleared.